| Medical and Health Sciences | Lifetime | 833 | GB 95 | 99.96 |
| Obstetrics and Gynecology | Lifetime | 13 | GB 4 | 99.87 |
| Reproductive Medicine | Lifetime | 20 | GB 2 | 99.86 |
| Surgery | Lifetime | 500 | GB 35 | 99.56 |
| Epidemiology | Lifetime | 766 | GB 65 | 98.97 |
| Rheumatology | Lifetime | 275 | GB 30 | 98.88 |
| Pulmonary and Respiratory Medicine | Lifetime | 780 | GB 54 | 98.81 |
| Pathology and Forensic Medicine | Lifetime | 746 | GB 63 | 96.52 |
| Dermatology | Lifetime | 608 | GB 54 | 94.66 |
| Obstetrics and Gynecology | 2021-2025 | 29 | GB 6 | 99.33 |
| Reproductive Medicine | 2021-2025 | 39 | GB 4 | 99.12 |
| Epidemiology | 2021-2025 | 857 | GB 78 | 91.47 |
| Surgery | 2021-2025 | 937 | GB 64 | 91.26 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 6 | GB 1 | 99.85 |
| Uterine Myomas and Treatments | Lifetime | 8 | GB 1 | 99.84 |
| Ovarian cancer diagnosis and treatment | Lifetime | 23 | GB 2 | 99.78 |
| Urologic and reproductive health conditions | Lifetime | 26 | GB 1 | 99.75 |
| Endometriosis Research and Treatment | Lifetime | 40 | GB 6 | 99.56 |
| Cervical Cancer and HPV Research | Lifetime | 59 | GB 6 | 99.58 |
| Sarcoma Diagnosis and Treatment | Lifetime | 98 | GB 5 | 99.50 |
| Soft tissue tumor case studies | Lifetime | 25 | GB 2 | 99.55 |
| Metastasis and carcinoma case studies | Lifetime | 61 | GB 2 | 99.11 |
| Cancer and Skin Lesions | Lifetime | 50 | GB 5 | 99.31 |
| Genital Health and Disease | Lifetime | 61 | GB 5 | 99.28 |
| Urinary and Genital Oncology Studies | Lifetime | 71 | GB 5 | 99.37 |
| Chromatin Remodeling and Cancer | Lifetime | 24 | GB 1 | 99.10 |
| Renal and related cancers | Lifetime | 135 | GB 11 | 99.13 |
| Gestational Trophoblastic Disease Studies | Lifetime | 20 | GB 7 | 98.76 |
| Gynecological conditions and treatments | Lifetime | 55 | GB 4 | 99.14 |
| Renal cell carcinoma treatment | Lifetime | 259 | GB 11 | 98.73 |
| Neuroendocrine Tumor Research Advances | Lifetime | 328 | GB 19 | 98.74 |
| Colorectal and Anal Carcinomas | Lifetime | 209 | GB 19 | 98.42 |
| Reproductive System and Pregnancy | Lifetime | 351 | GB 41 | 98.05 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 139 | GB 6 | 98.02 |
| Testicular diseases and treatments | Lifetime | 168 | GB 14 | 97.96 |
| Cancer Mechanisms and Therapy | Lifetime | 265 | GB 10 | 97.28 |
| Soft tissue tumors and treatment | Lifetime | 61 | GB 8 | 96.27 |
| Ear and Head Tumors | Lifetime | 628 | GB 30 | 94.49 |
| Kruppel-like factors research | Lifetime | 526 | GB 30 | 91.40 |
| Vascular Tumors and Angiosarcomas | Lifetime | 684 | GB 39 | 92.44 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 33 | GB 2 | 99.27 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 46 | GB 7 | 99.10 |
| Chromatin Remodeling and Cancer | 2021-2025 | 8 | GB 2 | 96.36 |
| Uterine Myomas and Treatments | 2021-2025 | 28 | GB 3 | 98.88 |
| Cervical Cancer and HPV Research | 2021-2025 | 50 | GB 6 | 98.30 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 266 | GB 16 | 94.85 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 459 | GB 19 | 91.72 |
| Cancer and Skin Lesions | 2021-2025 | 176 | GB 4 | 86.47 |
| Renal and related cancers | 2021-2025 | 486 | GB 28 | 87.71 |
| Congenital Diaphragmatic Hernia Studies | 2021-2025 | 510 | GB 29 | 85.30 |
| Testicular diseases and treatments | 2021-2025 | 440 | GB 23 | 73.23 |
| Tumors and Oncological Cases | 2021-2025 | 574 | GB 19 | 69.49 |